84年鼠女哪年财运最旺,857comvvv色九欧美激情|85PO_87国产精品欲av国产av资源

[1]莊至坤,郭金花,趙巖,等.股骨頭壞死髖關(guān)節(jié)疼痛和活動(dòng)度與ARCO分期的相關(guān)性分析[J].中醫(yī)正骨,2020,32(01):21-24.
點(diǎn)擊復(fù)制

股骨頭壞死髖關(guān)節(jié)疼痛和活動(dòng)度與ARCO分期的相關(guān)性分析()
分享到:

《中醫(yī)正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第32卷
期數(shù):
2020年01期
頁(yè)碼:
21-24
欄目:
專家述評(píng)
出版日期:
2020-01-20

文章信息/Info

作者:
莊至坤1郭金花1趙巖2薛志鵬2陳衛(wèi)衡3
(1.泉州市正骨醫(yī)院,福建 泉州 362000; 2.中國(guó)中醫(yī)科學(xué)院望京醫(yī)院,北京 100102; 3.北京中醫(yī)藥大學(xué)第三附屬醫(yī)院,北京 100029)
關(guān)鍵詞:
股骨頭壞死 髖關(guān)節(jié) 疼痛 關(guān)節(jié)活動(dòng)度 ARCO分期 數(shù)據(jù)庫(kù)
摘要:
目的:分析股骨頭壞死髖關(guān)節(jié)疼痛和活動(dòng)度與ARCO分期的相關(guān)性。方法:從中國(guó)股骨頭壞死數(shù)據(jù)庫(kù)(China osteonecrosis of the femoral head database,CONFHD)中提取2016年7月至2018年12月就診的ONFH患者的病例資料,提取年齡、ARCO分期、髖關(guān)節(jié)疼痛視覺模擬量表(visual analogue scale,VAS)評(píng)分、髖關(guān)節(jié)活動(dòng)度等信息。提取的所有資料均為患者到CONFHD參與醫(yī)院初次就診時(shí)的資料。分析髖關(guān)節(jié)疼痛VAS評(píng)分和髖關(guān)節(jié)6個(gè)方向活動(dòng)度與ARCO分期的相關(guān)性。結(jié)果:1590例ONFH患者的病例資料中同時(shí)錄入了ARCO分期和髖關(guān)節(jié)疼痛VAS評(píng)分,涉及2429髖。患者的ARCO分期以Ⅱ、Ⅲ期為主,占71%。ONFH患者的髖關(guān)節(jié)疼痛VAS評(píng)分與ARCO分期呈正相關(guān)(rs=0.102,P=0.000),Ⅲ、Ⅳ期患者的髖關(guān)節(jié)疼痛VAS評(píng)分較為接近。1378例ONFH患者的病例資料中同時(shí)錄入了ARCO分期和髖關(guān)節(jié)屈曲、后伸、內(nèi)收、外展、內(nèi)旋、外旋活動(dòng)度,涉及2068髖。ONFH患者的髖關(guān)節(jié)屈曲、后伸、內(nèi)收、外展、內(nèi)旋、外旋活動(dòng)度均與ARCO分期呈負(fù)相關(guān)(rs=-0.233,P=0.000; rs=-0.248,P=0.000; rs=-0.180,P=0.000; rs=-0.210,P=0.000; rs=-0.302,P=0.000; rs=-0.171,P=0.000)。結(jié)論:隨著ARCO分期的增加,ONFH患者的髖關(guān)節(jié)疼痛程度隨之增強(qiáng),病變后期患者的髖關(guān)節(jié)疼痛趨于穩(wěn)定; 髖關(guān)節(jié)各個(gè)方向的活動(dòng)度隨著ARCO分期的增加而下降。

參考文獻(xiàn)/References:

[1] FU W,LIU B,WANG B,et al.Early diagnosis and treatment of steroid-induced osteonecrosis of the femoral head[J].Int Orthop,2019,43(5):1083-1087.
[2] GARDENIERS J W M.Report of the committee of staging and nomenclature[EB/OL].(1993-10-14)[2019-08-01].http://arco-intl.org/Newsletters/Gardeniers-1993-5-2/Gardeniers-1993.htm.
[3] MONT M A,HUNGERFORD D S.Non-traumatic avascular necrosis of the femoral head[J].J Bone Joint Surg Am,1995,77(3):459-474.
[4] 廖小平.成年人與未成年人:多學(xué)科的界定[J].江西社會(huì)科學(xué),2008(6):202-205.
[5] NILSDOTTER A,BREMANDER A.Measures of hip function and symptoms:Harris hip score(HHS),hip disability and osteoarthritis outcome score(HOOS),Oxford hip score(OHS),Lequesne index of severity for osteoarthritis of the hip(LISOH),and American Academy of Orthopedic Surgeons(AAOS)hip and knee questionnaire[J].Arthritis Care Res(Hoboken),2011,63(Suppl 11):S200-S207.
[6] 孫偉,李子榮.股骨頭壞死的分期與分型[J].中國(guó)骨與關(guān)節(jié)雜志,2017,6(6):465-468.
[7] ANDO W,YAMAMOTO K,KOYAMA T,et al.Radiologic and clinical features of misdiagnosed idiopathic osteonecrosis of the femoral head[J].Orthopedics.2017,40(1):e117-e123.
[8] MIN H,XU F,GU R,et al.Potential diagnostic role of diffusion tensor imaging in early-stage osteonecrosis of the femoral head[J].Exp Ther Med,2016,12(5):3347-3352.
[9] 李祥瑞,劉海.CT與MRI在股骨頭壞死患者早期診斷及臨床分期中的應(yīng)用價(jià)值[J].臨床醫(yī)學(xué)研究與實(shí)踐,2018,3(28):142-143.
[10] CHOI H R,STEINBERG M E,Y CHENG E.Osteonecrosis of the femoral head:diagnosis and classification systems[J].Curr Rev Musculoskelet Med,2015,8(3):210-220.
[11] ZHAO D,XIE H,XU Y,et al.Management of osteonecrosis of the femoral head with pedicled iliac bone flap transfer:a multicenter study of 2190 patients[J].Microsurgery,2017,37(8):896-901.
[12] LI J,WANG J,ZHAO J,et al.BOLD-MRI early detect femoral head osteonecrosis following steroid-treated patients[J].Medicine(Baltimore),2017,96(44):e8401.
[13] KOMPEL A,MURAKAMI A,GUERMAZI A.Magnetic resonance imaging of nontraumatic musculoskeletal emergencies[J].Magn Reson Imaging Clin N Am,2016,24(2):369-389.
[14] CHEE C G,CHO J,KANG Y,et al.Diagnostic accuracy of digital radiography for the diagnosis of osteonecrosis of the femoral head,revisited[J].Acta Radiol,2019,60(8):969-976.
[15] 陳雷雷,張穎.何偉教授采用中醫(yī)藥療法治療股骨頭壞死的經(jīng)驗(yàn)[J].中醫(yī)正骨,2015,27(10):74-77.
[16] NAKAMURA J,KONNO K,ORITA S,et al.Distribution of hip pain in patients with idiopathic osteonecrosis of the femoral head[J].Mod Rheumatol,2017,27(3):503-507.
[17] OSAWA Y,SEKI T,TAKEGAMI Y,et al.Do femoral head collapse and the contralateral condition affect patient-reported quality of life and referral pain in patients with osteonecrosis of the femoral head[J].Int Orthop,2018, 42(7):1463-1468.
[18] FICAT R P.Treatment of avascular necrosis of the femoral head[J].Hip,1983:279-295.
[19] HUANG G S,CHAN W P,CHANG Y C,et al.MR imaging of bone marrow edema and joint effusion in patients with osteonecrosis of the femoral head:relationship to pain[J].AJR Am J Roentgenol,2003,181(2):545-549.
[20] ZOU D,ZHANG K,YANG Y,et al.Th17 and IL-17 exhibit higher levels in osteonecrosis of the femoral head and have a positive correlation with severity of pain[J].Endokrynol Pol,2018,69(3):283-290.
[21] 劉丙立,趙剛,王雪,等.早中期股骨頭壞死疼痛與壞死面積及關(guān)節(jié)積液分級(jí)相關(guān)性分析[J].實(shí)用骨科雜志,2015,21(11):1001-1004.
[22] YAMATO K,KATAOKA T,NISHIYAMA Y,et al.Antinociceptive effects of radon inhalation on formalin-induced inflammatory pain in mice[J].Inflammation,2013,36(2):355-363.
[23] JI R R,XU Z Z,GAO Y J.Emerging targets in neuroinflammation-driven chronic pain[J].Nat Rev Drug Discov,2014,13(7):533-548.
[24] 邱柱雄.非創(chuàng)傷性股骨頭壞死不同壞死分期和髖關(guān)節(jié)功能等級(jí)下髖關(guān)節(jié)積液發(fā)生情況[J].中國(guó)醫(yī)學(xué)創(chuàng)新,2018,15(21):121-124.

相似文獻(xiàn)/References:

[1]陳雷雷,張穎.何偉教授采用中醫(yī)藥療法治療股骨頭壞死的經(jīng)驗(yàn)[J].中醫(yī)正骨,2015,27(10):74.
[2]徐西林,趙永蘭,張曉峰,等.活骨注射液髖關(guān)節(jié)腔灌注對(duì)兔股骨頭壞死模型 血管內(nèi)皮生長(zhǎng)因子表達(dá)的動(dòng)態(tài)影響[J].中醫(yī)正骨,2015,27(08):1.
 XU Xilin,ZHAO Yonglan,ZHANG Xiaofeng,et al.Dynamic effect of intra-articular hip injection of Huogu injection on the expression of vascular endothelial growth factor in rabbit models with femur head necrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):1.
[3]周勇,任菲菲,豐凡翔,等.血管內(nèi)皮生長(zhǎng)因子和骨形態(tài)發(fā)生蛋白2 在非創(chuàng)傷性股骨頭壞死不同區(qū)域的表達(dá)[J].中醫(yī)正骨,2015,27(08):7.
 ZHOU Yong,REN Feifei,FENG Fanxiang,et al.Expressions of vascular endothelial growth factor and bone morphogenetic protein 2 in different zones of femoral head with non-traumatic osteonecrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):7.
[4]鮑榮華,王國(guó)平,夏曉斌,等.鉭棒植入治療非創(chuàng)傷性股骨頭壞死的療效觀察[J].中醫(yī)正骨,2015,27(02):28.
[5]張兵,馬凰富,劉波,等.非創(chuàng)傷性股骨頭壞死的舌象定量研究[J].中醫(yī)正骨,2015,27(04):8.
 ZHANG Bing,MA Huangfu,LIU Bo,et al.Quantitative study on tongue manifestation of patients with nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):8.
[6]李剛,程春生.股骨頭壞死血瘀證癥狀與平樂郭氏正骨方藥藥物組成 最大頻繁關(guān)聯(lián)模式挖掘[J].中醫(yī)正骨,2015,27(04):21.
 LI Gang,CHENG Chunsheng.Maximal frequent association pattern mining for studying the relationship between BLOOD STASIS syndrome in patients with osteonecrosis of femoral head and drug components of Pingle Guo's orthopedics prescription[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):21.
[7]李文龍,梅沉成,杜貴強(qiáng),等.微創(chuàng)減壓植骨多孔鉭棒植入治療 ARCOⅡ期非創(chuàng)傷性缺血性股骨頭壞死[J].中醫(yī)正骨,2016,28(02):43.
[8]張磊,金紅婷,童培建.骨健口服液早期干預(yù)非創(chuàng)傷性股骨頭壞死的臨床研究[J].中醫(yī)正骨,2016,28(03):14.
 ZHANG Lei,JIN Hongting,TONG Peijian.Clinical study on Gujian Koufuye(骨健口服液)for early intervention of nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(01):14.
[9]鮑榮華,王國(guó)平,夏曉斌,等.直接前入路微創(chuàng)全髖關(guān)節(jié)置換術(shù)治療晚期股骨頭壞死[J].中醫(yī)正骨,2016,28(03):61.
[10]張超,姚晨,沈計(jì)榮.微創(chuàng)髓芯減壓打壓支撐植骨術(shù)結(jié)合補(bǔ)腎活血湯口服治療ARCOⅡ、Ⅲ期股骨頭壞死的近期療效觀察[J].中醫(yī)正骨,2016,28(03):20.
 ZHANG Chao,YAO Chen,SHEN Jirong.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(01):20.
[11]洪志楠,宋雨珂,何曉銘,等.股骨頭前、外側(cè)保留角和聯(lián)合保留角在股骨頭壞死經(jīng)髖關(guān)節(jié)外科脫位打壓植骨支撐術(shù)適應(yīng)證選擇中的作用[J].中醫(yī)正骨,2024,36(09):69.
 HONG Zhinan,SONG Yuke,HE Xiaoming,et al.The role of anterior,lateral and combined preserved angles of femoral head in the selection of indications for impaction bone grafting through surgical hip dislocation approach for treating osteonecrosis of the femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2024,36(01):69.

備注/Memo

備注/Memo:
(收稿日期:2019-08-23 本文編輯:李曉樂)基金項(xiàng)目:國(guó)家中醫(yī)藥管理局國(guó)家中醫(yī)臨床研究基地業(yè)務(wù)建設(shè)科研專項(xiàng)課題(JDZX2015272); 北京市自然科學(xué)基金項(xiàng)目(7182186)通訊作者:陳衛(wèi)衡 E-mail:[email protected]
更新日期/Last Update: 2020-01-15